A guide to the five-layer tools stack that institutional biotech investors use to gain an edge: pipeline intelligence, financial data, deal tracking, real-world evidence, and signal detection.
Together AI raised $800M at $8.3B valuation for its AI-optimized public cloud. The neocloud infrastructure market is growing rapidly as enterprises shift to open-source AI models. Analysis of strategy, risks, and next signals.
The Bothell-based space mobility startup secured $50M from Geodesic Capital, Mach33 and Booz Allen to scale production of its solar thermal propulsion spacecraft.
Anduril is negotiating a new funding round at roughly $100 billion, only eight weeks after a $5 billion Series H. At 45 times trailing revenue, investors are pricing a bet that autonomous systems replace legacy platforms.
Culture Biosciences closed its Series C to scale the Stratyx 250 and Console AI platform. The digital biomanufacturing market is projected at $22.16B by 2034. Three models are competing to define the infrastructure standard.
deltaVision, a German fluidic systems manufacturer, raised €10.2M in its first external round to scale production of valves and pumps for in-orbit refueling. Profitable since 2022.
A field comparison of five AI drug discovery platforms — Isomorphic Labs, Recursion, Insitro, Insilico Medicine, and Schrödinger — their approaches, data, and odds of surviving to approval.
KelAI raised $5M in seed funding to build an autonomous AI research engine for hedge funds. Its signals have been running with an institutional investor since October 2025.
Get daily updates on the technologies and investment opportunities shaping the next decade — from AI infrastructure and autonomous systems to biotech, space, and defence. Curated analysis, no noise.
